News

Takeda completes sale of select OTC and Non-Core Assets to Acino

The transaction includes approximately 30 select prescription pharmaceutical and OTC products. These products will continue to be made available by Takeda in other parts of the world.

Mar 03, 2020

By : Team ABLE

UNITY Biotechnology appoints Anirvan Ghoshas Chief Executive Officer

Dr. Ghosh joins UNITY from Biogen, where he served as Senior Vice President, Head of Research and Early Development.

Mar 03, 2020

By : Team ABLE

Genpro Research expands India operations into Baroda and Kochi

Genpro uses its clinical expertise to provide digital platforms that help its customers get their product to market in a timely cost-effective manner.

Mar 03, 2020

By : Team ABLE

USDA announces $100 million for higher biofuel blends infrastructure

Higher biofuel blends include ethanol blends of 15% or higher, and biodiesel blends of 20% and above.

Mar 03, 2020

By : Team ABLE

Gilead to acquire Forty Seven for $4.9 billion

Through the addition of Forty Seven’s investigational lead product candidate, magrolimab, the acquisition will strengthen Gilead’s immuno-oncology research and development portfolio

Mar 03, 2020

By : Team ABLE